Home › Trials › NCT07351461
Clinical trial Recruiting at 1 site Observational Ages 18 and up

Anxiety in men on active surveillance for localized prostate cancer and their partners

Official title: Quantitative and Qualitative Study of Anxiety in Patients Under Active Surveillance for Localized Prostate Cancer and Their Partners.

Run by University Hospital, Lille · NCT07351461 · Data updated 2026-11-12

This project will see how much anxiety men on active surveillance for localized prostate cancer and their partners experience.

More Prostate Cancer trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment432 (estimated)
SponsorUniversity Hospital, Lille
Academic / other
Drugs / interventionsradiation
Locations1 site (Lille)
StatusRecruiting
StartedMarch 23, 2025
Main results expectedMarch 23, 2027
Study endsMarch 23, 2027
Registry record updatedJanuary 20, 2026
Trial IDNCT07351461 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are French-speaking adults (age ≥18) with localized prostate cancer who began active surveillance between 2007 and 2023, are followed at Lille University Hospital, have social security coverage, and have a life partner willing to participate.

Probably not a fit

Patients without a partner, those not followed at Lille University Hospital, non–French speakers, those lacking social security coverage, or men on definitive treatment rather than active surveillance are unlikely to benefit directly.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center observational study at Lille University Hospital will recruit men who began active surveillance for localized prostate cancer between 2007 and 2023 and their life partners. Participants will complete validated anxiety questionnaires and may be invited to qualitative interviews to describe emotional symptoms and coping. Clinical data from routine PSA tests, MRI scans, and biopsies will be combined with survey and interview data to explore factors linked to anxiety in both patients and partners. The aim is to better characterize the emotional burden and identify needs for targeted psychosocial support.

Why it matters

Potential benefit: If successful, the findings could lead to better-targeted psychological support and counseling to reduce anxiety and improve quality of life for patients and their partners.

How similar studies have gone: Previous research on anxiety during active surveillance has been limited and has mostly focused on patients alone, so jointly measuring patient and partner anxiety is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Age ≥ 18 years.
* Patients who started active surveillance for localized prostate cancer from 2007 to 2023 and are followed in the Urology Department of Lille University Hospital.
* Affiliation to a social security scheme.
* Obtaining patient consent.
* Having a life partner or an unidentified partner recognized as the person sharing the patient's daily life

Exclusion Criteria:

* Lack of proficiency in the French language.
* Minor patients, those under legal protection measures, or deprived of liberty.
* Lack of medical insurance coverage.
* Patients refusing to participate in the study.

Where it's running

  • CHU de Lille
    Lille, France     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Prostate Cancer 1464University Hospital, Lille 119
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.